Specialties
Novel Therapies and Lifesaving Innovations
Home to the country’s largest destination therapy LVAD program and nationally recognized specialty clinics, we deliver excellent outcomes across the full spectrum of heart failure care.
2026 Outcomes
Our multidisciplinary heart recovery program brings together heart failure cardiologists, surgeons, advanced care practitioners, nurse navigators and nurse coordinators—each driven to deliver the most advanced treatments and tailored care plans. The team’s steadfast commitment to patient-centered care has fueled our program’s impressive growth and exceptional outcomes.
ECMO Survival, April 2025 - March 2026
full-spectrum mechanical circulatory support (mcs)
Strong survival rates for Impella-supported high-risk and cardiogenic shock patients
Comprehensive temporary MCS to permanent destination therapy
Active site for the INNOVATE trial evaluating next-generation BrioVAD® technology
centers of excellence
Foundation for Sarcoidosis Research
Amyloidosis and sarcoidosis clinics
Nationally recognized, dedicated programs delivering highly targeted care
American Heart Association
Hypertrophic cardiomyopathy (HCM) clinic
Advanced therapy protocols and targeted infusion for complex HCM management
CLINICAL TRIALS
We actively participate in mechanical circulatory support trials, including the INNOVATE and BrioVAD clinical study.
Regional footprint across DFW
Our broad regional access provides patients across the Dallas-Fort Worth metropolitan area with access to advanced surgical interventions, nationally recognized specialty clinics and seamless transitions from inpatient to outpatient care.
Quality Awards 2026
Ranked among the nation's elite
Heart & Vascular Surgery
